BGC > Produktsuche > Imatinib mesylate

Appearance	white powder
Specification	99%Min

Molecular Formula: C29H31N7O.CH4O3S
Molecular Weight: 589.71

Description:
Imatinib (INN), marketed by Novartis as Gleevec (Canada, South Africa and the USA) or Glivec (Australia, Europe and Latin America), and sometimes referred to by its investigational name STI-571, is a tyrosine-kinase inhibitor used in the treatment of multiple cancers, most notably Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML).

• Molecular Weight:589.71
• Melting Point:214-224°C
• Purity:>98%

Molecular Formula:
C29H31N7O.CH4SO3
Canonical SMILES:
CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O
InChI:
InChI=1S/C29H31N7O.CH4O3S/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36;1-5(2,3)4/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34);1H3,(H,2,3,4)
InChIKey:
YLMAHDNUQAMNNX-UHFFFAOYSA-N
Appearance:
White or off-white crystalline powder
Storage: 2-8°C
Synonyms:
CGP-57148B; CGP 57148B; CGP57148B; Gleevec, Imatinib

Purity: 99%
Smile code: O=C(NC1=CC=C(C)C(NC2=NC=CC(C3=CC=CN=C3)=N2)=C1)C4=CC=C(CN5CCN(C)CC5)C=C4.CS(=O)(O)=O
MDL Number: MFCD04307699
MolFormula: C30H35N7O4S
MolWeight: 589.7084
Available in stock: 1129.815